Axsome Therapeutics, Inc. (AXSM) › Net IncomeAxsome Therapeutics, Inc. (AXSM) — Net IncomeAnnual figures by fiscal year, from SEC filings.2014: -$6.00M2015: -$12.21M2016: -$27.20M2017: -$28.94M2018: -$30.97M2019: -$68.35M2020: -$102.90M2021: -$130.40M2022: -$187.13M2023: -$239.24M2024: -$287.22M2025: -$183.17M-$183.17M2014Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$183.17M+36.2%2024-$287.22M-20.1%2023-$239.24M-27.8%2022-$187.13M-43.5%2021-$130.40M-26.7%2020-$102.90M-50.6%2019-$68.35M-120.7%2018-$30.97M-7.0%2017-$28.94M-6.4%2016-$27.20M-122.8%2015-$12.21M-103.5%2014-$6.00M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share